Australia; New Zealand; SA
A drug called magnesium sulphate doesn't appear to improve the likelihood of having a child without cerebral palsy when given to mothers at risk of imminent preterm birth between the 30th and 34th weeks of pregnancy, according to Australian research. While previous studies have shown the drug improves the chances of preterm babies surviving without cerebral palsy, how well it works for very premature babies compared to those born at around the 30-34 week mark was unclear. This study suggests there was no benefit for children born between 30 and 34 weeks gestation. The authors say the ways that brain injuries lead to cerebral palsy may be different in very premature babies compared with those born at later gestational ages.
From:
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
